Back to Journals » Drug Design, Development and Therapy » Volume 12

Abemaciclib: a CDK4/6 inhibitor for the treatment of HR+/HER2– advanced breast cancer

Total article views   Abstract views HTML views PDF downloads Totals
17,676 Dovepress* 8,036 3,828+ 1,767 11,864
PubMed Central* 0 5,812 1,088 5,812
Totals 8,036 9,640 2,855 17,676
*Since 16 February 2018
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar